Ophthalmology · New York, NY
NPI
1265751820
Since 2010
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
310 E 14th St, Suite 319 South
New York, NY, 10003
Phone (212) 979-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
2,177 services
Medicare patients, 2024
384
Average age 75
Drug cost, 2024
$964K
5,486 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kateki Vinod was code 92014 (ophthalmological e&m), 466 times for 310 patients. In total Kateki Vinod billed 2,177 services in 31 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 466 | 310 | $96.31 | $45K |
| 92012 Ophthalmological E&M | Office | 365 | 189 | $69.19 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 349 | 280 | $49.44 | $17K |
| 92202 Ophthalmological E&M | Office | 321 | 295 | $13.03 | $4,182 |
| 92133 Computerized Ophthalmic Imaging | Office | 301 | 282 | $27.62 | $8,314 |
| 92250 Angiography | Office | 173 | 172 | $30.68 | $5,308 |
| 99214 Office E&M - Established | Office | 48 | 46 | $110.77 | $5,317 |
| 76514 Ultrasound - Nonspecific | Office | 40 | 40 | $9.27 | $371 |
| 92020 Ophthalmological E&M | Office | 30 | 22 | $24.07 | $722 |
| 99204 Office E&M - New | Office | 17 | 17 | $147.44 | $2,506 |
By year: 2022 $112K for 1,645 services; 2023 $132K for 1,899 services; 2024 $130K for 2,177 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kateki Vinod prescribed most often to Medicare patients was Latanoprost, with 1,160 prescriptions and refills. In total Kateki Vinod wrote 5,486 Medicare prescriptions that cost $964K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,160 | 1,854 | 242 | $9,101 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 655 | 1,196 | 146 | $9,705 |
| Brimonidine Tartrate Generic | 425 | 737 | 102 | $44K |
| Rhopressa Netarsudil Mesylate | 392 | 541 | 80 | $175K |
| Timolol Maleate Generic | 284 | 530 | 72 | $6,781 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 264 | 348 | 50 | $117K |
| Vyzulta Latanoprostene Bunod | 259 | 379 | 53 | $102K |
| Combigan Brimonidine Tartrate/Timolol | 202 | 367 | 45 | $86K |
| Lumigan Bimatoprost | 189 | 310 | 46 | $82K |
| Alphagan P Brimonidine Tartrate | 175 | 301 | 46 | $75K |
| Dorzolamide Hcl Generic | 174 | 329 | 41 | $2,807 |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 132 | 222 | 35 | $17K |
| Simbrinza Brinzolamide/Brimonidine Tart | 128 | 193 | 30 | $29K |
| Prednisolone Acetate Generic | 120 | 210 | 54 | $5,648 |
| Brinzolamide Generic | 104 | 191 | 25 | $18K |
Brand drugs: - claims; generic drugs: 3,010 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kateki Vinod were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.